Douglas Corley to Stomach Neoplasms
This is a "connection" page, showing publications Douglas Corley has written about Stomach Neoplasms.
Connection Strength
4.201
-
Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population. Am J Gastroenterol. 2020 05; 115(5):706-715.
Score: 0.685
-
Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort. Gut. 2018 03; 67(3):418-529.
Score: 0.544
-
Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors. Aliment Pharmacol Ther. 2016 Jan; 43(1):73-82.
Score: 0.502
-
Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008 Feb; 17(2):352-8.
Score: 0.293
-
Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? Gut. 2007 Nov; 56(11):1493-4.
Score: 0.288
-
Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. Am J Gastroenterol. 2007 Oct; 102(10):2323-30; quiz 2331.
Score: 0.281
-
Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):872-8.
Score: 0.260
-
Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst. 2004 Sep 15; 96(18):1383-7.
Score: 0.232
-
Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004 Apr; 99(4):582-8.
Score: 0.225
-
Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer. 2002 Nov 15; 95(10):2096-102.
Score: 0.204
-
Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar; 122(3):633-40.
Score: 0.194
-
Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol. 2001 Dec; 30(6):1415-25.
Score: 0.191
-
Diet and upper gastrointestinal malignancies. Gastroenterology. 2015 May; 148(6):1234-1243.e4.
Score: 0.119
-
Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology. 2012 Mar; 142(3):442-452.e5; quiz e22-3.
Score: 0.095
-
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010 Sep 08; 102(17):1344-53.
Score: 0.087